Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Patients With Type 2 Diabetes
Efficacy of Ultrasound-Guided Thoracolumbar Fascia Injection in the Treatment of Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
This prospective, randomized, controlled clinical trial aims to evaluate the efficacy of ultrasound-guided thoracolumbar fascia (TLF) injection as an adjunct to standard conservative treatment in patients with type 2 diabetes mellitus and chronic nonspecific low back pain.
A total of 60 patients aged 18-65 years, diagnosed with type 2 diabetes mellitus for at least one year and experiencing chronic nonspecific low back pain for at least three months, will be enrolled. Eligible participants will be randomly assigned to two groups. The intervention group will receive ultrasound-guided thoracolumbar fascia injection in addition to standard conservative treatment, while the control group will receive standard conservative treatment alone, consisting of patient education and a structured exercise program.
Clinical assessments will be performed at baseline and at 1 and 3 months after treatment. Treatment outcomes will include pain intensity measured using the Numeric Rating Scale (NRS), functional disability assessed using the Oswestry Disability Index (ODI), pressure pain threshold (PPT) measured by algometry, and analgesic consumption.
Thoracolumbar fascia thickness will be measured using ultrasonography at baseline to investigate its potential association with treatment response. Diabetes-related characteristics, including HbA1c levels, diabetes duration, and peripheral neuropathy status, will also be recorded.
The primary objective is to determine whether adding ultrasound-guided thoracolumbar fascia injection to standard conservative treatment provides greater improvement in pain intensity and functional disability compared with standard conservative treatment alone. The study will also explore whether baseline thoracolumbar fascia thickness and diabetes-related characteristics are associated with clinical outcomes.
調査の概要
状態
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Hatice Zehra FERHATLAR, MD
- 電話番号:05367387869
- メール:haticezehraferhatlar@gmail.com
研究場所
-
-
Istanbul
-
Küçükçekmece、Istanbul、トルコ(Türkiye)、34307
- 募集
- Kanuni Sultan Suleyman Training and Research Hospital
-
コンタクト:
- Hatice Zehra FERHATLAR, MD
- 電話番号:05367387869
- メール:haticezehraferhatlar@gmail.com
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
**Inclusion Criteria:**
- Age between 18 and 65 years.
- Diagnosis of type 2 diabetes mellitus for at least 1 year.
- Chronic low back pain lasting at least 3 months.
- Nonspecific or mechanical low back pain.
- Baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).
- Pain or tenderness on palpation over the thoracolumbar fascia region.
- Willingness to participate in the study.
- Provision of written informed consent.
**Exclusion Criteria:**
- Radiculopathy or significant neurological deficits.
- Neurogenic claudication due to spinal stenosis.
- Spinal tumor or infection.
- History or presence of vertebral fracture.
- Inflammatory rheumatic disease.
- Spinal surgery within the previous 6 months.
- Injection in the lumbar region within the previous 3 months.
- Anticoagulant therapy or conditions contraindicating injection.
- Active infection at the injection site.
- Severe systemic disease, including advanced renal failure.
- Uncontrolled diabetic metabolic condition.
- Pregnancy.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Thoracolumbar Fascia Injection Group
|
A single ultrasound-guided thoracolumbar fascia injection will be performed with the patient in the prone position under aseptic conditions. Using an in-plane technique, a 22-gauge needle will be advanced into the middle layer of the thoracolumbar fascia between the quadratus lumborum and erector spinae muscles at the L4 level. Correct needle placement will be confirmed by hydrodissection using approximately 2 mL of local anesthetic. Subsequently, 10 mL of 0.25% bupivacaine and 40 mg of methylprednisolone acetate will be administered into the interfascial plane. Standard conservative treatment will consist of structured patient education and a home-based exercise program. The exercise program will include lumbopelvic and core stabilization exercises, abdominal and paraspinal muscle strengthening, hip muscle strengthening, lower extremity stretching, and aerobic activity as tolerated. Participants will receive instructions on correct exercise techniques, maintaining daily activities, and avoiding prolonged bed rest. The program will be recommended for regular home practice throughout the study period. |
|
アクティブコンパレータ:Standard Conservative Treatment Group
|
Standard conservative treatment will consist of structured patient education and a home-based exercise program. The exercise program will include lumbopelvic and core stabilization exercises, abdominal and paraspinal muscle strengthening, hip muscle strengthening, lower extremity stretching, and aerobic activity as tolerated. Participants will receive instructions on correct exercise techniques, maintaining daily activities, and avoiding prolonged bed rest. The program will be recommended for regular home practice throughout the study period. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change in Low Back Pain Intensity Measured by the Numeric Rating Scale (NRS)
時間枠:Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change in Functional Disability Measured by the Oswestry Disability Index (ODI)
時間枠:Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
|
Change in Pressure Pain Threshold (PPT) Measured by Algometry
時間枠:Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
|
Change in Analgesic Consumption During Follow-up
時間枠:Baseline to Month 3
|
Baseline to Month 3
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Ahiskalioglu A, Yayik AM, Celik EC, Aydin ME, Uzun G. Ultrasound guided modified Thoracolumbar Interfascial Plane block for low back pain management. J Clin Anesth. 2019 May;54:138-139. doi: 10.1016/j.jclinane.2018.11.010. Epub 2018 Nov 28. No abstract available.
- Okmen BM, Okmen K. Effectiveness of the Ultrasound-Guided Interfascial Injection Applied in Addition to Physical Therapy Applications in Chronic Low Back Pain: A Quasi-Experimental Study. Eurasian J Med. 2024 Feb;56(1):56-60. doi: 10.5152/eurasianjmed.2024.23286.
- Lv Y, Wu J, Xu Y, Pu S, Li C, Du D. A novel approach to ultrasound-guided L3-4 thoracolumbar fascia injection for chronic pain after spine surgery: a prospective pilot study. BMC Anesthesiol. 2025 May 15;25(1):243. doi: 10.1186/s12871-025-03046-6.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。